glp-1/gip/gcg receptor agonist Regulation of GLP-1 and Glucagon Function by β-Arrestins in Metabolically Important Cell Types GLP-1-based therapies for type 2

Future work should focus on therapeutic strategies to improve antioxidant mechanisms in these children, with a possible improvement in longer-term respiratory outcomes

One way to improve the poor bioavailability of nutraceuticals is to co-administer a potent bioenhancer, such as piperine, from black pepper [149]

For treatment via i.p

Claim: Safer because its oral Reality: Route does not equal safety

The current recommendations remain those of following a carbohydrates-rich diet with a limited fats intake and reducing, even excluding, physical activity, without, however, taking into account the long-term consequences of this approach